HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 140 filers reported holding HERON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,532 | -41.1% | 22,847 | -33.7% | 0.00% | – |
| Q2 2023 | $39,955 | -81.4% | 34,444 | -75.8% | 0.00% | – |
| Q1 2023 | $215,192 | -34.1% | 142,511 | +9.1% | 0.00% | -100.0% |
| Q4 2022 | $326,603 | -45.7% | 130,641 | -8.4% | 0.00% | 0.0% |
| Q3 2022 | $602,000 | +65.4% | 142,681 | +9.3% | 0.00% | 0.0% |
| Q2 2022 | $364,000 | -48.4% | 130,569 | +6.0% | 0.00% | 0.0% |
| Q1 2022 | $705,000 | -41.3% | 123,171 | -6.5% | 0.00% | 0.0% |
| Q4 2021 | $1,202,000 | -12.9% | 131,666 | +2.0% | 0.00% | -50.0% |
| Q3 2021 | $1,380,000 | -30.2% | 129,071 | +1.3% | 0.00% | 0.0% |
| Q2 2021 | $1,977,000 | -7.7% | 127,394 | -3.6% | 0.00% | -33.3% |
| Q1 2021 | $2,142,000 | -23.6% | 132,138 | -0.3% | 0.00% | -25.0% |
| Q4 2020 | $2,804,000 | +42.8% | 132,486 | 0.0% | 0.00% | +33.3% |
| Q3 2020 | $1,963,000 | +1.0% | 132,486 | +0.3% | 0.00% | 0.0% |
| Q2 2020 | $1,944,000 | +29.6% | 132,122 | +3.4% | 0.00% | 0.0% |
| Q1 2020 | $1,500,000 | -50.3% | 127,751 | -0.5% | 0.00% | -40.0% |
| Q4 2019 | $3,017,000 | +41.8% | 128,385 | +11.6% | 0.01% | +25.0% |
| Q3 2019 | $2,128,000 | +0.8% | 115,007 | +1.2% | 0.00% | 0.0% |
| Q2 2019 | $2,112,000 | -18.1% | 113,631 | +7.7% | 0.00% | -20.0% |
| Q1 2019 | $2,579,000 | -7.9% | 105,542 | -2.2% | 0.01% | -16.7% |
| Q4 2018 | $2,799,000 | -16.1% | 107,888 | +2.3% | 0.01% | 0.0% |
| Q3 2018 | $3,338,000 | -12.0% | 105,455 | +8.0% | 0.01% | -25.0% |
| Q2 2018 | $3,793,000 | +66.2% | 97,644 | +18.1% | 0.01% | +60.0% |
| Q1 2018 | $2,282,000 | +76.1% | 82,695 | +15.5% | 0.01% | +66.7% |
| Q4 2017 | $1,296,000 | +10.5% | 71,613 | -1.4% | 0.00% | 0.0% |
| Q3 2017 | $1,173,000 | +5.2% | 72,611 | -9.8% | 0.00% | +50.0% |
| Q2 2017 | $1,115,000 | -9.9% | 80,532 | -2.4% | 0.00% | -33.3% |
| Q1 2017 | $1,238,000 | +44.3% | 82,532 | +25.9% | 0.00% | +50.0% |
| Q4 2016 | $858,000 | -26.0% | 65,532 | -2.7% | 0.00% | 0.0% |
| Q3 2016 | $1,160,000 | -3.6% | 67,332 | +1.1% | 0.00% | -33.3% |
| Q2 2016 | $1,203,000 | +2.4% | 66,632 | +7.6% | 0.00% | 0.0% |
| Q1 2016 | $1,175,000 | -18.8% | 61,900 | +14.2% | 0.00% | -25.0% |
| Q4 2015 | $1,447,000 | +11.5% | 54,211 | +1.9% | 0.00% | +33.3% |
| Q3 2015 | $1,298,000 | -7.5% | 53,211 | +18.2% | 0.00% | 0.0% |
| Q2 2015 | $1,403,000 | +127.0% | 45,011 | +5.9% | 0.00% | +200.0% |
| Q1 2015 | $618,000 | +43.1% | 42,488 | -1.2% | 0.00% | 0.0% |
| Q4 2014 | $432,000 | +21.0% | 42,988 | +0.4% | 0.00% | 0.0% |
| Q3 2014 | $357,000 | -18.3% | 42,804 | +20.6% | 0.00% | 0.0% |
| Q2 2014 | $437,000 | – | 35,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |